The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Total antioxidant capacity and total oxidant status in patients with major depression: Impact of antidepressant treatment
Abstract
Aim: The purpose of the present study was to investigate whether total antioxidant capacity (TAC) and total oxidant status (TOS) are associated with major depressive disorder (MDD) and to evaluate the impact of antidepressant treatment on TAC and TOS in MDD. Methods: Fifty‐seven MDD patients and 40 healthy controls participated in the study. Serum TAC and TOS were measured both in patients and controls using Erel's methods. Patients were treated with antidepressant drugs for 12 weeks. The treatment course was evaluated using the Montgomery–Asberg Depression Rating Scale (MADRS) in all patients. Results: TOS and oxidative stress index (OSI) were higher (P = 0.0001 for both) and TAC was lower (P = 0.0001) in the MDD group compared with those of the controls. After 3 months of antidepressant treatment, TOS and OSI were decreased and TAC was increased compared with the pretreatment values (P = 0.0001, for all). Furthermore, there were significant positive correlations between the severity of the disease and serum TOS and OSI (r = 0.584,P = 0.0001; r = 0.636,P = 0.0001, respectively). A negative correlation was found between the severity of the disease and serum TAC (r = −0.553,P = 0.0001) at the pre‐treatment stage. Conclusion: Treatment administered for 3 months to MDD patients increases TAC while decreasing TOS and OSI.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Individuals who suffer with MDD display lower serum/plasmatic total antioxidant potentials [28, 32, 48] and reduced brain GSH levels [31] as compared to matched controls.”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [32]
In the citing paper
“TOS and OSI were higher and TAC level was lower in the MDD group compared with controls (n = 40).”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [32]
In the citing paper
“Furthermore, the authors found a positive correlation between the severity of the disease and serum TOS and OSI (r = 0.58, and r = 0.63, resp.).”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [32]
In the citing paper
“Also, a negative correlation was found between the severity of the disease and serum TAC (r = −0.553) at the pretreatment stage.”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [32]
In the citing paper
“After 3 months of treatment with escitalopram, 10–20 mg/day, n = 10; paroxetine, 20–40 mg/day, n = 20; or sertraline, 50–100 mg/day, n = 27, TOS and OSI were decreased and TAC was increased compared with pretreatment values [32].”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [32]
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Tissue Destruction by Neutrophils
Epstein, F. H., & Weiss, S. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200606 · Cited by 3,950
A new automated colorimetric method for measuring total oxidant status
Erel, Ö. (2005) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2005.08.008 · Cited by 3,747
Tissue Destruction by Neutrophils
(1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210513 · Cited by 3,634
Erel, Ö. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2003.11.015 · Cited by 2,940
Antioxidants in health and disease
Young, I. S., & Woodside, J. V. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.3.176 · Cited by 1,949
A novel automated method to measure total antioxidant response against potent free radical reactions
Erel, Ö. (2003) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2003.10.014 · Cited by 1,771
Handbook of Psychiatric Measures
Salzman, C. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1343 · Cited by 1,172
Research works printed but not linked: 2
- First MB, 1997, Structured Clinical Interview for DSM‐IV Clinical Version (SCID‐I/CV)
- Corapcioglu A, 1999, Structured Clinical Interview for DSM‐IV (SCID‐IV)
Cited by
Sorted by citations
Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140
Leonard, B., & Maes, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.005 · Cited by 805
Gawryluk, J. W., Wang, J.-F., Andreazza, A. C., Shao, L., & Young, L. T. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000805 · Cited by 594
A Meta-analysis of oxidative stress markers in depression
Liu, T., Zhong, S., Liao, X., Chen, J., He, T., Lai, S., & Jia, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138904 · Cited by 485
Wolkowitz, O. M., Mellon, S. H., Epel, E. S., Lin, J., Dhabhar, F. S., Su, Y., Reus, V. I., Rosser, R., Burke, H. M., Kupferman, E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017837 · Cited by 421
Oxidative stress in anxiety and comorbid disorders
Hovatta, I., Juhila, J., & Donner, J. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.08.007 · Cited by 365
Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression
Allen, J., Romay-Tallón, R., Brymer, K. J., Caruncho, H. J., & Kalynchuk, L. E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00386 · Cited by 362
Maes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0111-7 · Cited by 325
Depression gets old fast: do stress and depression accelerate cell aging?
Wolkowitz, O. M., Epel, E. S., Reus, V. I., & Mellon, S. H. (2010) · Depression and Anxiety · doi:10.1002/da.20686 · Cited by 298
Depression and Oxidative Stress: Results From a Meta-Analysis of Observational Studies
Palta, P., Samuel, L. J., Miller, E. R., & Szanton, S. L. (2014) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000009 · Cited by 277
Shelton, R. C., & Miller, A. H. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.004 · Cited by 264
Smaga, I., Niedzielska, E., Gawlik, M., Moniczewski, A., Krzek, J., Przegaliński, E., Pera, J., & Filip, M. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.12.015 · Cited by 252
Of sound mind and body: depression, disease, and accelerated aging
Wolkowitz, O. M., Reus, V. I., & Mellon, S. H. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/owolkowitz · Cited by 214
Fruit, vegetable, and antioxidant intakes are lower in older adults with depression
Payne, M. E., Steck, S. E., George, R. R., & Steffens, D. C. (2012) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2012.08.026 · Cited by 211
Behr, G. A., Moreira, J. C. F., & Frey, B. N. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/609421 · Cited by 205
Martins‐de‐Souza, D., Guest, P. C., Harris, L. W., Vanattou‐Saïfoudine, N., Webster, M. J., Rahmoune, H., & Bahn, S. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.13 · Cited by 202
Peripheral Markers of Depression
Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197
Antioxidants as Antidepressants
Scapagnini, G., Davinelli, S., Drago, F., LORENZO, A. D., & Oriani, G. (2012) · CNS Drugs · doi:10.2165/11633190-000000000-00000 · Cited by 188
Maes, M., Ruckoanich, P., Chang, Y. S., Mahanonda, N., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.008 · Cited by 169
Du, J., Zhu, M. F., Bao, H., Bai, L., Dong, Y., Xiao, C., Zhang, G. Y., Henter, I. D., Rudorfer, M. V., & Vitiello, B. (2014) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2013.876960 · Cited by 164
Lopresti, A. L., Hood, S. D., & Drummond, P. D. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112458732 · Cited by 151
Oxidative/Nitrosative Stress and Immuno-inflammatory Pathways in Depression: Treatment Implications
Anderson, G., & Maes, M. H. J. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660738 · Cited by 148
Rybka, J., Kędziora-Kornatowska, K., Banaś-Leżańska, P., Majsterek, I., Carvalho, L. A., Cattaneo, A., Anacker, C., & Kędziora, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.019 · Cited by 146
The role of mitochondria in mood disorders: from physiology to pathophysiology and to treatment
Giménez-Palomo, A., Dodd, S., Anmella, G., Carvalho, A. F., Scaini, G., Quevedo, J., Pacchiarotti, I., Vieta, E., & Berk, M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.546801 · Cited by 140
Inflammation in depression: is adiposity a cause?
Shelton, R. C., & Miller, A. H. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/rshelton · Cited by 143
Oxidative stress markers in affective disorders
Siwek, M., Sowa-Kućma, M., Dudek, D., Styczeń, K., Szewczyk, B., Kotarska, K., Misztak, P., Pilc, A., Wolak, M., & Nowak, G. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71517-2 · Cited by 142
Serum total oxidant/antioxidant status and trace element levels in breast cancer patients
Feng, J., Lu, L. H., Zeng, P., Yang, Y.-H., Luo, J. P., Yang, Y., & Wang, D. (2011) · International Journal of Clinical Oncology · doi:10.1007/s10147-011-0327-y · Cited by 131
Cognitive Dysfunction in Depression – Pathophysiology and Novel Targets
Carvalho, A., Miskowiak, K., Hyphantis, T., Kohler, C., Alves, G., Bortolato, B., G. Sales, P., Machado-Vieira, R., Berk, M., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130203627 · Cited by 107
Bahadoran, Z., Mirmiran, P., Hosseinpanah, F., Hedayati, M., Hosseinpour‐Niazi, S., & Azizi, F. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.59 · Cited by 108
Antioxidant and Anti-Inflammatory Effects of Carotenoids in Mood Disorders: An Overview
Rasmus, P., & Kozłowska, E. (2023) · Antioxidants · doi:10.3390/antiox12030676 · Cited by 102
Increased oxidative stress in patients with depression and its relationship to treatment
Chung, C. P., Schmidt, D. E., Stein, C. M., Morrow, J. D., & Salomon, R. M. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.10.018 · Cited by 99
Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice
da Silva, F. C. C., Citó, M. D. C. D. O., Silva, M. I. G., Moura, B. A., Neto, M. R. D. A., Feitosa, M. L., Chaves, R. D. C., Macêdo, D. S., Vasconcelos, S. M. M., Fonteles, M. M. D. F., et al. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.05.011 · Cited by 99
Anderson, G., Berk, M., Dean, O. M., Moylan, S., & Maes, M. H. J. (2013) · CNS Drugs · doi:10.1007/s40263-013-0119-1 · Cited by 95
Abshirini, M., Siassi, F., Koohdani, F., Qorbani, M., Mozaffari, H., Aslani, Z., Soleymani, M., Entezarian, M., & Sotoudeh, G. (2019) · Annals of General Psychiatry · doi:10.1186/s12991-019-0225-7 · Cited by 91
Tayeb, A. E. K. A., Poinsignon, V., Chappell, K., Bouligand, J., Becquemont, L., & Verstuyft, C. (2023) · Antioxidants · doi:10.3390/antiox12040942 · Cited by 100
Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients
Zhang, X., Zhang, Z., Xie, C., Xi, G., Zhou, H., Zhang, Y., & Sha, W. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.01.004 · Cited by 88
Abdel-Wahab, B. A., & Salama, R. H. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.07.015 · Cited by 86
Zheng, W., Zhang, Q. ‐., Cai, D., Yang, X.-H., Qiu, Y., Ungvari, G. S., Ng, C. H., Berk, M., Ning, Y., & Xiang, Y. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12862 · Cited by 83
Prohan, M., Amani, R., Nematpour, S., Jomehzadeh, N., & Haghighizadeh, M. H. (2014) · Redox Report · doi:10.1179/1351000214y.0000000085 · Cited by 77
Nguyen, H. D., Oh, H., Hoang, N. H. M., Jo, W. H., & Kim, M. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-15986-w · Cited by 75
Rossetti, A. C., Paladini, M. S., Riva, M. A., & Molteni, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107520 · Cited by 73
Oxidative stress and glutathione response in tissue cultures from persons with major depression
Gibson, S. A., Korade, Ž., & Shelton, R. C. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.06.008 · Cited by 71
Mohammadi, H. S., Goudarzi, I., Lashkarbolouki, T., Abrari, K., & Salmani, M. E. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.05.015 · Cited by 72
Clinical implications of lipid peroxidation in acne vulgaris: old wine in new bottles
Bowe, W. P., & Logan, A. C. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-141 · Cited by 69
Tane, A., Khalili‐Tanha, G., Esmaeili, A., Mobasheri, L., Kooshkaki, O., Jafari, S., Shokouhifar, A., & Sarab, G. A. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01401-0 · Cited by 63
Miller, E. D., Mrowicka, M., Malinowska, K., Mrowicki, J., Saluk, J., & Kędziora, J. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2010.518626 · Cited by 63
A pilot study of cortical glutathione in youth with depression
Freed, R. D., Hollenhorst, C. N., Weiduschat, N., Mao, X., Kang, G., Shungu, D. C., & Gabbay, V. (2017) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2017.10.001 · Cited by 74
Shafiee, M., Ahmadnezhad, M., Tayefi, M., Arekhi, S., Vatanparast, H., Esmaily, H., Moohebati, M., Ferns, G. A., Mokhber, N., Arefhosseini, S. R., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.05.079 · Cited by 62
Effect of treatment on serum glial cell line-derived neurotrophic factor in bipolar patients
Zhang, X., Zhang, Z., Sha, W., Xie, C., Xi, G., Zhou, H., & Zhang, Y. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.03.003 · Cited by 54
Oxidative and Nitrosative stress in major depressive disorder: a case control study
Somani, A., Singh, A. K., Gupta, B., Nagarkoti, S., Dalal, P. K., & Dikshit, M. (2022) · Brain Sciences · doi:10.3390/brainsci12020144 · Cited by 54
“Accordingly, antioxidant treatment has been shown to improve psychiatric symptoms in clinical trials [10].”
BackgroundWang, L., Li, X., Chen, X., Qin, X., Kardami, E., & Cheng, Y. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00377 · Cited by 50
Restorative Biological Processes and Health
Robles, T. F., & Carroll, J. (2011) · Social and Personality Psychology Compass · doi:10.1111/j.1751-9004.2011.00368.x · Cited by 51
Panahi, Y., Badeli, R., Karami, G.-R., Badeli, Z., & Sahebkar, A. (2015) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2015.06.010 · Cited by 47
Mellon, S. H., Wolkowitz, O. M., Schonemann, M. D., Epel, E. S., Rosser, R., Burke, H. B., Mahan, L., Reus, V. I., Stamatiou, D., Liew, C. C., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.79 · Cited by 46
Alıcı, D., Bülbül, F., Vırıt, O., Ünal, A., Altındağ, A., Alpak, G., Alıcı, H., Ermis, B., Örkmez, M., Tayşi, S., et al. (2015) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12362 · Cited by 44
Aydın, S., Ögetürk, M., Kuloğlu, T., Kavaklı, A., & Aydın, S. (2014) · Peptides · doi:10.1016/j.peptides.2014.11.008 · Cited by 44
Tagliari, B., dos Santos, T. M., da Cunha, A. A., de Lima, D. D., Delwing, D., Sitta, Â., Vargas, C. R., Dalmaz, C., & Wyse, Â. T. D. S. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0445-0 · Cited by 43
Black, C. N., Penninx, B. W. J. H., Bot, M., Odegaard, A., Gross, M., Matthews, K. A., & Jacobs, D. R. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.5 · Cited by 44
Evaluation of oxidative and antioxidative parameters in generalized anxiety disorder
Emhan, A., Selek, S., Bayazıt, H., Karababa, İ. F., Katı, M., & Aksoy, N. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.11.001 · Cited by 42
Antioxidants Prevent Memory Deficits Provoked by Chronic Variable Stress in Rats
Tagliari, B., Scherer, E. B. D. S., Machado, F. R., Ferreira, A. G. K., Dalmaz, C., & Wyse, Â. T. D. S. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0563-6 · Cited by 39
Ornoy, A., Becker, M., Weinstein‐Fudim, L., & Ergaz, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103721 · Cited by 37
Talarowska, M. E., Gałecki, P., Maes, M. H. J., Bobińska, K., & Kowalczyk, E. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0788-z · Cited by 35
Lyngdoh, T., Bochud, M., Glaus, J., Castelao, E., Waeber, G., Vollenweider, P., & Preisig, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076336 · Cited by 34
Berkiks, I., Benmhammed, H., Mesfioui, A., Ouichou, A., hasnaoui, A. E., Mouden, S., Touil, T., Bahbiti, Y., Nakache, R., & Hessni, A. E. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2017.1398156 · Cited by 35
Acute administration of Zn, Mg, and thiamine improves postpartum depression conditions in mice.
Nikseresht, S., Etebary, S., Karimian, M., Nabavizadeh, F., Zarrindast, M., & Sadeghipour, H. R. (2012) · PubMed · Cited by 33
Chronic depression as a model disease for cerebral aging
Bewernick, B. H., & Schlaepfer, T. E. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.1/bbewernick · Cited by 31
Ciubuc-Batcu, M. T., Stapelberg, N. J. C., Headrick, J. P., & Renshaw, G. M. C. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166920 · Cited by 31
Chang, C., Lee, C.-T., Lan, T., Ju, P., Hsieh, Y., & Lai, T.-J. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.10.006 · Cited by 29
Anxiety, neuroticism and oxidative stress: Cross‐sectional study in non‐smoking college students
Matsushita, M., Kumano‐go, T., Suganuma, N., Adachi, H., Yamamura, S., Morishima, H., Shigedo, Y., Mikami, A., Takeda, M., & Sugita, Y. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02109.x · Cited by 31
Redox proteomics and drug development
D’Alessandro, A., Rinalducci, S., & Zolla, L. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.01.001 · Cited by 27
Lima, E. B. C., de Sousa, C. N. S., Vasconcelos, G. S., Meneses, L. N., Pereira, Y. F. E. S., Ximenes, N. C., Júnior, M. A. S., Matos, N. C. B., Brito, R., Miron, D., et al. (2016) · Journal of Natural Medicines · doi:10.1007/s11418-016-0970-8 · Cited by 27
The Relationship between Suicide and Oxidative Stress in a Group of Psychiatric Inpatients
Koweszko, T., Gierus, J., Zalewska, A., Maciejczyk, M., Waszkiewicz, N., & Szulc, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113462 · Cited by 25
Linck, V. M., Costa-Campos, L., Pilz, L. K., Garcia, C. R. L., & Elisabetsky, E. (2012) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283512c3a · Cited by 26
Piubelli, C., Vighini, M., Mathé, A. A., Domenici, E., & Carboni, L. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001318 · Cited by 26
Hussain, H., Ahmad, S., Shah, S. W. A., Ullah, A., Almehmadi, M. M., Abdulaziz, O., Allahyani, M. A., Alsaiari, A. A., Halawi, M., & Alamer, E. (2022) · Biomedicines · doi:10.3390/biomedicines10102385 · Cited by 26
Thiol disulfide homeostasis in psychiatric disorders: A comprehensive review
Tunçay, M. E., Atagün, M. İ., & Erel, Ö. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110719 · Cited by 25
Fluoxetine a novel anti-hepatitis C virus agent via ROS-, JNK-, and PPARβ/γ-dependent pathways
Young, K.-C., Bai, C., Su, H., Tsai, P., Pu, C.-Y., Liao, C., Lin, Y., Lai, H.-W., Chong, L.-W., Tsai, Y.-S., et al. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.08.002 · Cited by 26
The neurodegenerative hypothesis of depression and the influence of antidepressant medications
Hall, S., Parr, B.-A., Hussey, S., Anoopkumar‐Dukie, S., Arora, D. S., & Grant, G. D. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176967 · Cited by 26
Yuluğ, B., Hanoğlu, L., Tavlı, A. M., lmaz, N. H. Y., & c, E. K. L. (2016) · Medicinal Chemistry · doi:10.2174/1573406411666151005110321 · Cited by 23
Oliveira, P. S., Gazal, M., Flores, N. P., Zimmer, A. R., Chaves, V. C., Reginatto, F. H., Kaster, M. P., Tavares, R. G., Spanevello, R. M., Lencina, C. L., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.121 · Cited by 23
Doets, J. J. R., Topper, M., & Nugter, A. (2021) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2021.102783 · Cited by 22
Seo, M. K., Cho, H. Y., Lee, C. H., Koo, K. A., Park, Y. K., Lee, J. G., Lee, B. J., Park, S. W., & Kim, Y. H. (2013) · Psychiatry Investigation · doi:10.4306/pi.2013.10.1.81 · Cited by 22
de Mello, A. H., Souza, L. D. R., Cereja, A. C. M., Schraiber, R. D. B., Florentino, D., Martins, M. M., Petronilho, F. C., Quevedo, J., & Rezin, G. T. (2015) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12371 · Cited by 22
Acute-phase proteins, oxidative stress, and antioxidant defense in crib-biting horses
Omidi, ., Vakili, S., Nazıfı, S., & Parker, M. O. (2016) · Journal of Veterinary Behavior · doi:10.1016/j.jveb.2016.06.005 · Cited by 21
Bhat, M. A., & Gandhi, G. (2018) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2018.1475093 · Cited by 20
Maternal Depression Model: Long-Lasting Effects on the Mother Following Separation from Pups
Toigo, E. V. P., Diehl, L. A., Ferreira, A. G. K., Mackendanz, V., Krolow, R., Benitz, A. N. D., Noschang, C. G., Huffell, A. P., Silveira, P. P., Wyse, Â. T. D. S., et al. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0590-3 · Cited by 19
Antioxidant Activity and Nutritional Status in Anorexia Nervosa: Effects of Weight Recovery
Oliveras‐López, M., Ruiz-Prieto, I., Bolaños-Ríos, P., la Cerda, F. D., Martı́n, F., & Jáuregui-Lobera, I. (2015) · Nutrients · doi:10.3390/nu7042193 · Cited by 18
Prolidase activity and oxidative stress in patients with major depressive disorder.
Kokaçya, M. H., Bahçeci, B., Bahçeci, İ., Dilek, A. R., & Dokuyucu, R. (2014) · PubMed · Cited by 18
Kaźmierski, J., Miler, P., Pawlak, A., Jerczyńska, H., Woźniak, J., Frankowska, E., Brzezińska, A., Nowakowska, K., Woźniak, K., Krejca, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-03007-2 · Cited by 18
Baek, S.-E., Lee, G.-J., Rhee, C.-K., Rho, D.-Y., Kim, D.-H., Huh, S., & Lee, S.-K. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.2.222 · Cited by 17
Cumurcu, B. E., Özyurt, H., Ateş, Ö., Gül, I. G., Demir, S., & Karlidağ, R. (2013) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2013.2390 · Cited by 17
Self-citationYang, M., Liu, S., Hu, L., Zhan, J., Lei, P., & Wu, M. (2017) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2017.12.024 · Cited by 16
Sera total oxidant/antioxidant status in lung cancer patients
Xiang, M., Feng, J., Geng, L., Yang, Y., Dai, C., Li, J., Liao, Y., Wang, D., & Du, X. (2019) · Medicine · doi:10.1097/md.0000000000017179 · Cited by 16
cRGD mediated liposomes enhanced antidepressant-like effects of edaravone in rats
Qin, J., Zhang, R., Li, J., Wang, J., Hou, J., Yang, X., Zhu, W., Shi, J., & Lü, L. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.03.006 · Cited by 16
Han, C., Lim, Y., & Hong, Y. (2016) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.16.029 · Cited by 15
Evaluation of Oxidative Status in Patients Treated with Electroconvulsive Therapy
Şenyurt, M., Aybek, H., Herken, H., Kaptanoğlu, B., & Korkmaz, A. İ. (2017) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2017.15.1.40 · Cited by 15
Neuroprotective astroglial response to neural damage and its relevance to affective disorders
Miguel-Hidalgo, J. J. (2023) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2023.00054 · Cited by 14
Kaya, M., Bez, Y., Selek, S., Karababa, İ. F., Bulut, M., SAVAS, H. A., Çelık, H., & Herken, H. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.05.006 · Cited by 14
Deficiency of epithelial–mesenchymal transition causes child indirect inguinal hernia
Somuncu, S., Somuncu, O., Ballica, B., & Tabandeh, B. (2019) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2019.06.020 · Cited by 14
Mapping the structure of depression biomarker research: A bibliometric analysis
Guo, X., Wu, P., Jia, X. P., Dong, Y., Zhao, C., Chen, N., Zhang, Z., Miao, Y.-T., Yun, K., Gao, C., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.943996 · Cited by 14
Metadata
- Authors
- Cumurcu, B. E., Ozyurt, H., Etikan, I., Demir, S., & Karlidag, R.
- Venue
- Psychiatry and Clinical Neurosciences
- Publisher
- Wiley
- Published
- 2009-09-23
- Volume
- 63
- Issue
- 5
- Pages
- 639-645
- ISSN
- 1323-1316 (ISSN-L)
- 1440-1819
- OpenAlex
- W1540420232
- Cited by
- 165
- References
- 29
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 8 · 2023: 13 · 2022: 12 · 2021: 11 · 2020: 6 · 2019: 8 · 2018: 5 · 2017: 9 · 2016: 10 · 2015: 12 · 2014: 13 · 2013: 9 · 2012: 12
- FWCI
- 8.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychiatry and Clinical Neurosciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- major depressive disorder, total antioxidant capacity, total oxidant status, oxidative stress, antidepressant treatment, oxidative stress index, depression severity, serum antioxidants
- MeSH terms
- Adult, Major Depressive Disorder, Female, Humans, Male, Oxidation-Reduction, Severity of Illness Index, Time Factors, Case-Control Studies, Oxidants, Selective Serotonin Reuptake Inhibitors, Reactive Oxygen Species, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review